Pharmacogenomics and Immunosuppression in solid organ transplant patients
The purpose of this activity is to provide pharmacy technicians and pharmacists with the information and skills for the use of pharmacogenomics when initiating and managing immunosuppressive medications in solid organ transplant recipients. Variations in an individual’s genes can affect drug response, especially with the pharmacokinetics and pharmacodynamics of medications used in maintenance immunosuppression that have a narrow therapeutic index. Based on specific phenotypes, therapy plans for transplant immunosuppression can become more personalized to each patient. This will assist in avoiding harmful adverse effects and toxicities, as well as reaching therapeutic outcomes.
- Pharmacy technicians
Pharmacist learning objectives
- Discuss the use of personalized medicine and pharmacogenomics in different patient populations.
- Characterize pharmacogenomic factors that could alter pharmacokinetics and pharmacodynamics of immunosuppressive medications.
- Apply the principles of pharmacogenomics to evaluate the appropriate use of immunosuppressive medications.
- Evaluate the literature for outcomes of pharmacogenomic-tailored therapy in solid organ transplant recipients.
Pharmacy technician learning objectives
- Identify adverse effects of agents used in maintenance immunosuppression after solid organ transplant.
Relevant financial relationships: Planning committee members and presenters have nothing to disclose.
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician